NCT07223190 2026-03-04
AUDAX
Amgen
Phase 3 Not yet recruiting
Clinical Trials
6 trialsNCT07387926 2026-02-04
Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
Novartis
Phase 1/2 Not yet recruiting
NCT06894693 2025-03-25
A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies
Guangdong Ruishun Biotech Co., Ltd
Phase 1 Not yet recruiting
NCT06641024 2024-10-15
Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL
Chongqing Precision Biotech Co., Ltd
Phase 1 Not yet recruiting
NCT06367114 2024-04-19
Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration)
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Phase 2 Not yet recruiting
NCT05381181 2023-01-27
Safety and Efficacy Evaluation of Next-generation CD19-UCART
Bioray Laboratories
Phase 1 Not yet recruiting